PI3K/AKT/mTOR signaling in cancer
Moving in bioRxiv, Oncogene, Journal of Clinical Investigation, Nature Cell Biology, Cell Death & Differentiation, Nature Communications, Cell Reports and eLife.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 61
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in PI3K/AKT/mTOR signaling in cancer
Newest first · last 60 days
AI summary · may contain errors
SIMMPYRA1 and SIMMPYRA2 suppress triple-negative breast cancer growth by selectively inhibiting STAT3 Y705 phosphorylation, blocking activation at low micromolar concentrations in PDX models.
AI summary · may contain errors
Elevated purines, especially deoxyguanosine (dG), suppress mTORC1 signaling by reducing RHEB activity through a TUFM-dependent control of RHEB nucleotide binding.
AI summary · may contain errors
Higher RHBDL2 expression is associated with chemoresistance and poor prognosis in patients with triple-negative breast cancer (TNBC), and RHBDL2 knockdown suppresses stemness and resistance in TNBC cells.
AI summary · may contain errors
Concurrent deletion of Akt1 and Akt3 isoforms in murine neurons is sufficient to rescue PTEN-loss–driven hypertrophic morphology and physiology, implicating AKT as the essential mediator.
- Open access
- 3 cites
AI summary · may contain errors
Suppressing IPMK or ITPK1 in pancreatic β-cells reduces IP5 and delays mTORC1-dependent metabolic acceleration under excess glucose, linked to faster mTORC1 signal termination.
- Open access
AI summary · may contain errors
LZK inhibition suppresses AKT activation and limits tumor growth in MAP3K13-amplified esophageal squamous cell carcinoma xenografts, with AKT phosphorylation at S473/T450 reduced.
- Open access
- 4 cites
AI summary · may contain errors
In human prostate tumors, PKA subunits show grade-dependent spatial redistribution—RIβ declines while PKAC shifts into proliferating Grade Group 4 cells—linked to stronger substrate phosphorylation.
- Open access
AI summary · may contain errors
In AGS gastric adenocarcinoma cells, PI3K inhibition combined with MEK or TAK1 inhibition shows synergy that concentrates at pathway convergence nodes, amplifying growth and survival control.
- Open access
- 2 cites
AI summary · may contain errors
Nuclear cGAS binding in human cells is recruited by AP-1 transcription factors and transcriptionally regulates cholesterol homeostasis, linking lipid control to tumor growth and therapy response.
- Open access
AI summary · may contain errors
METTL13-catalysed eEF1A lysine 55 dimethylation (eEF1AK55me2) enhances decoding of select codons, boosting pro-oncogenic protein synthesis linked to tumorigenesis and KRAS-inhibitor resistance.
- Open access
AI summary · may contain errors
SNOR, a fission yeast hibernation factor induced by perturbed glucose homeostasis, maintains dormant ribosomes in a state competent for rapid reactivation.
- Open access
AI summary · may contain errors
Targeting TerminaTOR to the nucleus specifically inhibits nuclear mTORC1 and reveals that nuclear mTORC1 regulates transcription of CCAAT motif-containing genes.
- Open access
- 2 cites
AI summary · may contain errors
PELO is elevated in patient-derived PTEN-low prostate tumors and is linked to higher Gleason scores, and PELO loss in Pten pc-/- mice blocks anterior prostate fluid accumulation.
AI summary · may contain errors
Disrupting fatty acid synthase (FASN)-driven de novo lipogenesis in triple-negative breast cancer suppresses metastasis and increases tumor-cell MHC-I antigen presentation and CD8+ T cell activation.
- Open access
AI summary · may contain errors
Isoleucine and valine, but not leucine, are necessary and sufficient for quiescence exit and T cell division, driven by distinct mTOR and c-Myc sensing rather than catabolism.
- Open access
AI summary · may contain errors
Three structurally distinct low-micromolar GCN2 activators were identified in cellulo, including one that activates GCN2 independently of GCN1.
- Open access
- 1 cites
AI summary · may contain errors
MiT/TFE transcription factors are central regulators of lysosomal function, mTORC1 signaling, and cellular metabolism, and their dysregulation is increasingly recognized as a key driver of kidney cancer.
AI summary · may contain errors
Cryo-EM structures of 48S pre-initiation complexes show 5MP1 bound at the A site, stabilizing an open PIC conformation to control start codon selection.
- Open access
- 2 cites
AI summary · may contain errors
Dafachronic acid, a steroid hormone, may transmit the effects of reduced mTOR activity across tissues to coordinate metabolism and longevity across the body.
- Open access
Browse JClub
Journals this month
- bioRxiv6357
- medRxiv1736
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
